# Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

> **NCT01324141** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 6 (actual)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** Tempol
- **DRUG:** 5-Fluorouracil
- **DRUG:** Mitomycin-C
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01324141
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03-18
- **Primary completion:** 2015-04-15
- **Final completion:** 2015-04-15
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow, insufficient accrual and failure to meet endpoints.
- **Last updated:** 2021-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324141, "Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01324141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*